«RNAi therapies are a unique approach to cancer treatment as they have the potential to «turn off» the genes» coding for proteins involved in cancer cell division,» said Ramesh K. Ramanathan, M.D., medical director of the Virginia G. Piper Cancer Center Clinical Trials Program at Scottsdale Healthcare and deputy director of
the Clinical Translational Research Division of the Translational Genomics Research Institute (TGen) in Phoenix, Ariz. «Using a lipid nanoparticle, the RNAi drug can be delivered to a cancer cell to block the expression of specific proteins involved in tumor growth.»
Dr. Azorsa is currently an associate professor in TGen's
Clinical Translational Research Division and a research assistant professor in the Department of Basic Medical Science at the University of Arizona College of Medicine — Phoenix.
Not exact matches
Not all CTSA programs bolster
translational research in the same way, points out NCRR Division Director of Clinical Research Anthony
research in the same way, points out NCRR
Division Director of
Clinical Research Anthony
Research Anthony Hayward.
The aim of the
division is to develop
translational research programmes and
clinical research, but any significant progress toward the cure of cancer can only be based on an improved understanding of its pathogenesis, which, in turn, will lead to the development of improved diagnostics and more rationale therapeutic interventions.
Dr. Georgia L. Wiesner is an Ingram Professor of Cancer
Research, Professor of Medicine in the
Division of Genetic Medicine and the Director of the new
Clinical and
Translational Hereditary Cancer Program for the Vanderbilt - Ingram Cancer Center.
«While we expected we might find the associations to be weaker in the healthy lifestyle group, we did not expect them to completely disappear,» said Mingyang Song, MD, a
research fellow in the Massachusetts General Hospital
Clinical and
Translational Epidemiology Unit and
Division of Gastroenterology, in a press release.
Vice Chancellor
Clinical and
Translational Research Director, Duke
Translational Medicine Institute Professor of Medicine
Division of Cardiology Duke University Medical Center